Speaker Profile
Chief Commercial Officer, Ambry Genetics
Biography
Tom Schoenherr comes to Ambry with more than 20 years of experience in the molecular diagnostics space, most recently as the CCO of Omada Health where he was responsible for driving business growth and increasing market share. He also served in similar roles at Counsyl, Quest Diagnostics, Siemens Healthcare, and Abbott Diagnostics. As Ambry’s Chief Commercial Officer, Tom is responsible for the execution of Ambry’s go-to-market strategy and oversees all commercial functions including service, support, sales, marketing, business development, managed care and genetic specialists. Tom earned his BS from Michigan State University and completed his Executive Business Development Program from the University of Notre Dame.
Clinical Dx Showcase:
Ambry Genetics
Since 1999, our mission has remained focused on understanding disease better so cures can come faster. Through our ongoing research, we give health care providers clearer information so they can accurately guide patient care.
Accelerating Precision Medicine Solutions Through Multi-Disciplinary Platforms
Session Abstract – PMWC 2020 Silicon Valley
The PMWC 2020 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
